Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal logo Université Clermont Auvergne & associés

Human Nutrition Unit

Zone de texte éditable et éditée et rééditée

Frédéric CAPEL, PhD

Activities

Email : contact
Tel : +33(0)4 73 60 82 62

Frédéric Capel

I've obtained a PhD (2004) in Life Sciences on the relationship between the loss of skeletal muscle with aging and the alterations in mitochondrial functions (energy & reactive oxygen species productions). Between 2005 and 2010, I had the opportunity to be introduced to functional genomic to study the regulation of gene expression in insulin-sensitive tissues depending on population (obese, elderly people) nutritional status. In 2010, I joined the Human Nutrition Unit of the INRA as a research scientist. I work on nutritional strategies based on dietary fats to prevent metabolic disorders linked to excess body fat. It is now well established that the quality of dietary fatty acids is crucial in the prevention of many pathologies. Some classes of fatty acids could help at preventing the accumulation of deleterious lipid metabolites and some metabolic disorders or inflammation. I used both in vitro (cellular approaches) and in vivo/physiological (animal models, human interventions) to understand and modify the relationship between lipid metabolism, adipose tissue and skeletal muscle physiology.

Research Activities

Ongoing projects are related to the effect of omega 3 PUFAs in the prevention of obesity-associated metabolic disorders:

Prevention of the accumulation of toxic lipid metabolites in skeletal muscle (phospholipids, diacylglycerols, ceramides) and the progression of inflammation

Impact on the development of adipose tissue and modulation of its metabolism

In vitro analysis of the physiologic/metabolic relationship between adipose and muscle cells

Other projects concerned the identification of lipid markers (fatty acids, phospholipids) of metabolic disorders (in relation with clinicians) or specific dietary intakes.

Publications

  • Capel, F., C. Acquaviva, et al. (2015). "DHA at nutritional doses restores insulin sensitivity in skeletal muscle by preventing lipotoxicity and inflammation." J Nutr Biochem 26(9): 949-959.
  • Capel, F., N. Cheraiti, et al. (2016). "Oleate dose-dependently regulates palmitate metabolism and insulin signaling in C2C12 myotubes." Biochim Biophys Acta 1861(12 Pt A): 2000-2010.
  • Capel, F., E. Klimcakova, et al. (2009). "Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization." Diabetes 58(7): 1558-1567.
  • Ennequin, G., F. Capel, F et al. (2017). "Neuregulin 1 improves complex 2-mediated mitochondrial respiration in skeletal muscle of healthy and diabetic mice." Sci Rep 7(1): 1742.
  • Pinel, A., E. Pitois, et al. (2016). "EPA prevents fat mass expansion and metabolic disturbances in mice fed with a Western diet." J Lipid Res.
  • Pinel, A., J. P. Rigaudiere, et al. (2015). "N-3PUFA differentially modulate palmitate-induced lipotoxicity through alterations of its metabolism in C2C12 muscle cells." Biochim Biophys Acta.

Curriculum Vitae

Since 2010: INRA, Unité de Nutrition Humaine, Clermont-Ferrand-Theix, France

2008-10: Institut de Recherches Servier, Croissy-sur-Seine, France.

2005-08: INSERM U858 - Unité de Recherches sur les Obésités, Toulouse, France

2001-04: PhD, INRA, Unité de Nutrition et Métabolisme Protéique, Clermont-Ferrand-Theix, France

Research programs funded by IEED GENESYS P.I.V.E.R.T (3 programs 2013-2017), Avril, European FP7 program (NuAge -2016), ANSSD program of INRA (2011-2012) région Auvergne-FEDER (Prix nouveau chercheur 2015-2017 Région Auvergne)